FT825/ONO-8250

FT825/ONO-8250 · Fate Therapeutics; Ono Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FT825/ONO-8250, covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors [Phase 1]

See pricing